About this trial
Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopy and preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anaesthesia, intensive care and emergency medicine. ATI:FB is regarded as the gold standard of tracheal intubation in many scenarios, however there is insufficient data on the patients experience while undergoing this form of airway management. ATI:FB can be facilitated using either a transnasal or transoral route. The study aims to compare patient-centred and operator-focused outcome parameters between these two different approaches with a focus on patient discomfort.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients scheduled for surgery requiring tracheal intubation
patients with an anticipated difficult airway requiring ATI:FB
consent by the patient
minimum 18 years of age
Disqualifiers
patients scheduled for surgery requiring tracheal intubation
patients not scheduled for ATI:FB
pregnant or breastfeeding patients
consent withheld or not possible to obtain by the patient
Trial population
Patients scheduled for surgery requiring general anaesthesia at the study center university hospital medical center
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Patient reported discomfort experienced during ATI:FB
recorded on a visual analog scale (1-100; lower values better)
Secondary outcomes
Patient reported recall of the ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Patient reported pain experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Patient reported fear experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Patient reported feeling of suffocation experienced during ATI:FB
yes/no and on a visual analog scale (1-100; lower values better)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.